Lupus & Connective Tissue Diseases
Conference Coverage
TNF inhibitors may dampen COVID-19 severity
New findings from the COVID-19 Global Rheumatology Alliance Registry.
From the Journals
Proteins in urine may predict active lupus nephritis
The most predictive biomarkers varied across ethnicities, but phenotypic profiling may be a better way to define subsets of patients, a researcher...
Commentary
Advice on treating rheumatic diseases from a COVID-19 epicenter
Hospital for Special Surgery rheumatologists discuss their approach to caring for patients with rheumatic diseases within their practice during...
Guidelines
ACR gives guidance on rheumatic disease management during pandemic
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be...
Conference Coverage
Expert discusses red flags for interstitial lung disease in pediatric rheumatology
MAUI, HAWAII – Catch lung disease early in youths with juvenile dermatomyositis or systemic juvenile idiopathic arthritis.
From the Journals
Case series suggests biologics, JAK inhibitors safe during pandemic
Investigators saw no increase in hospitalizations versus the general population in New York City.
Conference Coverage
Use of cannabinoids in dermatology here to stay
Different state-based requirements exist for recommending cannabinoid products to your patients “so it’s important to know those requirements.”
Feature
Hospitals update hydroxychloroquine protocols after FDA warning
Some hospitals changed their use of hydroxychloroquine for patients with COVID-19 long before the FDA’s recent warning about the drug’s risks.
From the Journals
Dermatomyositis without dermatitis correlates with autoantibodies
In a cohort of patients with dermatomyositis, 8% did not have a rash at the time of muscle biopsy.
Feature
Latest data on COVID-19 patients with rheumatic diseases revealed in registry
Data for a total of 583 COVID-19 patients have now been made available.
Conference Coverage
Differentiating hypersensitivity reactions to monoclonal antibodies
MAUI, HAWAII – Who to send to the allergist for desensitization.